NEUROGENE INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.7 USD | +9.16% |
|
+7.81% | +70.28% |
| 01:30pm | Leerink Partners Starts Neurogene With Outperform Rating, $46 Price Target | MT |
| 03-22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
Quotes 5-day view
Delayed Quote Nasdaq| 23/04/2024 | 24/04/2024 | 25/04/2024 | 26/04/2024 | 29/04/2024 | |
|---|---|---|---|---|---|
| Last | 31.17 $ | 30.23 $ | 29.87 $ | 29.96 $ | 33 $ |
| Volume | 58 205 | 52 572 | 71 109 | 47 839 | 49 952 |
| Change | +1.83% | -3.02% | -1.19% | +0.30% | +9.16% |
| Opening | 30.70 | 30.96 | 29.09 | 29.89 | 31.66 |
| High | 33.08 | 30.96 | 29.96 | 31.52 | 33.21 |
| Low | 30.70 | 29.51 | 28.09 | 29.88 | 31.36 |
Performance
| 1 day | +9.16% | ||
| 1 week | +7.81% | ||
| Current month | -35.17% | ||
| 1 month | -29.46% | ||
| 3 months | +3.12% | ||
| Current year | +70.28% |
Volumes
marketsDaily volume
49 952
Estimated daily volume
71 491
Avg. Volume 20 sessions
91 661
Daily volume ratio
0.78
Avg. Volume 20 sessions USD
2 997 773.01
Record volume 1
643 857
Record volume 2
481 158
Record volume 3
411 713
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
385 455 892
Net sales (USD)
0
Number of employees
91
Sales / Employee (USD)
0
Free-Float
86.64 %
Free-Float capitalization (USD)
333 615 355
Average Daily Capital Traded
0.78%
Highs and lows
1 week
28.09
33.21
1 month
28.0951.22
Current year
19.0053.00
1 year
12.4953.00
3 years
12.4953.00
5 years
12.4953.00
10 years
12.4953.00
Indicators
Moving average 5 days
30.37
Moving average 20 days
37.99
Moving average 50 days
37.42
Moving average 100 days
30.56
Price spread / (MMA5)
-7.15%
Price spread / (MMA20)
+16.15%
Price spread / (MMA50)
+14.41%
Price spread / (MMA100)
-6.57%
STIM
RSI 9 days
21.26
RSI 14 days
29.52
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +9.16% | +7.81% | +70.28% | - | 385M | ||
| +0.99% | +2.44% | +2.42% | +24.73% | 42.75B | ||
| -1.02% | +3.08% | +47.70% | -5.60% | 41.61B | ||
| +3.11% | +6.61% | +11.98% | -16.52% | 41.34B | ||
| +4.02% | +6.25% | -8.83% | +14.38% | 26.59B | ||
| -1.70% | +1.74% | +7.08% | +55.08% | 25.49B | ||
| +2.96% | +1.62% | -22.60% | -26.61% | 18.12B | ||
| +1.02% | +6.44% | +30.65% | +93.95% | 12.24B | ||
| +1.05% | -0.28% | -1.90% | +21.99% | 11.76B | ||
| +2.58% | +2.63% | +9.24% | +3.49% | 11B | ||
| +1.59% | +3.54% | -15.73% | -17.94% | 10.07B | ||
| +1.31% | +2.35% | -5.77% | -8.57% | 9.22B | ||
| +0.12% | +3.57% | +24.92% | -15.11% | 6.65B | ||
| +3.41% | +20.21% | +8.55% | -34.40% | 6.44B | ||
| +2.04% | +0.96% | +28.24% | +54.21% | 6.13B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| Average | +1.92% | +3.29% | +12.41% | +10.22% | ||
| Weighted average by Cap. | +1.33% | +3.93% | +10.32% | +9.81% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
2bdc4c64d2ea9c52cfbe16.de6hvkoAvflxd-FgCFaJ6Q35CHdnfngrsPzpskS_M7E.LKno3S1p7psnT5k1exXion6DXScMMzZ_0c2s-x7MRvsRhZSPZ0fMnRYPoA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 18:59:34 | 33 | 100 | 29,992 |
| 18:59:27 | 33 | 118 | 29,892 |
| 18:59:27 | 32.99 | 100 | 29,774 |
| 18:56:25 | 32.96 | 100 | 29,674 |
| 18:56:15 | 32.68 | 100 | 29,574 |
| 18:56:15 | 32.68 | 112 | 29,474 |
| 18:56:15 | 32.67 | 103 | 29,362 |
| 18:56:15 | 32.63 | 100 | 29,259 |
| 18:56:15 | 32.62 | 100 | 29,159 |
| 18:56:15 | 32.62 | 100 | 29,059 |
Monthly variations
Annual change
| 2024 | +54.59% | ||
| 2023 | +28.34% |
- Stock Market
- Equities
- NGNE Stock
- Quotes Neurogene Inc.
